Neurology and Neurosurgery - Global Neurology Academy

257-272 of 525

Diagnosing Duchenne Muscular Dystrophy: Recognizing Signs and Reducing Delays
Diagnosing Duchenne Muscular Dystrophy: Recognizing Signs and Reducing Delays
NeuroFrontiers
Diagnosing Duchenne Muscular Dystrophy: Recognizing Signs and Reducing Delays
Nancy Kuntz, MD
- Nancy Kuntz, MD
Duchenne Muscular Dystrophy Management: Analyzing Current Approaches
Duchenne Muscular Dystrophy Management: Analyzing Current Approaches
NeuroFrontiers
Duchenne Muscular Dystrophy Management: Analyzing Current Approaches
Nancy Kuntz, MD
- Nancy Kuntz, MD
From Trials to Practice: Evaluating Xanomeline-Trospium Chloride for Schizophrenia
From Trials to Practice: Evaluating Xanomeline-Trospium Chloride for Schizophrenia
NeuroFrontiers
From Trials to Practice: Evaluating Xanomeline-Trospium Chloride for Schizophrenia
Ashley Baker, MSN, PMHNP; Steven Paul, MD
- Ashley Baker, MSN, PMHNP
- Steven Paul, MD
Exploring Metabolomics in Multiple Sclerosis
Exploring Metabolomics in Multiple Sclerosis
NeuroFrontiers
Exploring Metabolomics in Multiple Sclerosis
Pavan Barghava, MD
- Pavan Barghava, MD
Metabolomics in Multiple Sclerosis: Advancing Diagnosis, Prognosis, and Treatment Response
Metabolomics in Multiple Sclerosis: Advancing Diagnosis, Prognosis, and Treatment Response
NeuroFrontiers
Metabolomics in Multiple Sclerosis: Advancing Diagnosis, Prognosis, and Treatment Response
Pavan Barghava, MD
- Pavan Barghava, MD
Safety Outcomes in MS Clinical Trials: Examining Comorbidities and Adverse Events
Safety Outcomes in MS Clinical Trials: Examining Comorbidities and Adverse Events
NeuroFrontiers
Safety Outcomes in MS Clinical Trials: Examining Comorbidities and Adverse Events
Amber Salter, PhD
- Amber Salter, PhD
MS and the Ketogenic Diet: Potential Impacts on Inflammation and Relapse
MS and the Ketogenic Diet: Potential Impacts on Inflammation and Relapse
NeuroFrontiers
MS and the Ketogenic Diet: Potential Impacts on Inflammation and Relapse
Michael Kornberg, MD, PhD
- Michael Kornberg, MD, PhD
Managing Multiple Sclerosis: The Impact of Dietary Modifications
Managing Multiple Sclerosis: The Impact of Dietary Modifications
On the Frontlines of Multiple Sclerosis
Managing Multiple Sclerosis: The Impact of Dietary Modifications
Charles Turck, PharmD, BCPS, BCCCP; Anna A. Shah, MD
- Charles Turck, PharmD, BCPS, BCCCP
- Anna A. Shah, MD
Strategies and Considerations for Managing MS in Pregnant Women
Strategies and Considerations for Managing MS in Pregnant Women
On the Frontlines of Multiple Sclerosis
Strategies and Considerations for Managing MS in Pregnant Women
Charles Turck, PharmD, BCPS, BCCCP; Anna A. Shah, MD
- Charles Turck, PharmD, BCPS, BCCCP
- Anna A. Shah, MD
Emerging Technologies in MS: Neuromodulation and Myelin Regeneration
Emerging Technologies in MS: Neuromodulation and Myelin Regeneration
NeuroFrontiers
Emerging Technologies in MS: Neuromodulation and Myelin Regeneration
Cristin Welle, PhD
- Cristin Welle, PhD
Cognitive Impairment in MS: Mitigating Impacts to Optimize Brain Health
Cognitive Impairment in MS: Mitigating Impacts to Optimize Brain Health
NeuroFrontiers
Cognitive Impairment in MS: Mitigating Impacts to Optimize Brain Health
Christopher Lock, MD
- Christopher Lock, MD
MS and Structural Disconnectivity: Pathophysiology and Emerging Technologies
MS and Structural Disconnectivity: Pathophysiology and Emerging Technologies
NeuroFrontiers
MS and Structural Disconnectivity: Pathophysiology and Emerging Technologies
Amy Kuceyeski, PhD
- Amy Kuceyeski, PhD
Understanding Prodromal Phases in Demyelinating Diseases: Insights on MS, NMOSD, and MOGAD
Understanding Prodromal Phases in Demyelinating Diseases: Insights on MS, NMOSD, and MOGAD
NeuroFrontiers
Understanding Prodromal Phases in Demyelinating Diseases: Insights on MS, NMOSD, and MOGAD
Dalia Rotstein, MD, MPH
- Dalia Rotstein, MD, MPH
Multiple Sclerosis Explained: Understanding Its Epidemiology
Multiple Sclerosis Explained: Understanding Its Epidemiology
NeuroFrontiers
Multiple Sclerosis Explained: Understanding Its Epidemiology
Jonathan E. Howard, MD
- Jonathan E. Howard, MD
Generalized Myasthenia Gravis Management: Evaluating Long-Term Effects
Generalized Myasthenia Gravis Management: Evaluating Long-Term Effects
NeuroFrontiers
Generalized Myasthenia Gravis Management: Evaluating Long-Term Effects
Maxwell H. Levy, MD
- Maxwell H. Levy, MD
Genetics and Schizophrenia: Key Ethical Considerations
Genetics and Schizophrenia: Key Ethical Considerations
NeuroFrontiers
Genetics and Schizophrenia: Key Ethical Considerations
Aaron Besterman, MD
- Aaron Besterman, MD

17/11